Apex Shares Update in Patent Litigation

TAIPEI, Taiwan (Feb. 24, 2014)—Apex Medical Corporation, a leading player in the respiratory therapy and pressure area care sectors, announced that the United States Patent and Trademark Office (USPTO) agreed on Feb. 20 to reexamine the validity of five patents of ResMed, an Australia-based provider of sleep-disorder treatment products, which were asserted in patent litigation involving Apex.